Lactobacillus crispatus, specifically the Lactobacillus crispatus M247 strain, is a naturally occurring bacterium in the female urogenital tract with remarkable potential for vaginal colonization. It possesses resistance to certain treatments, produces lactic acid, and competes with harmful microorganisms.

This strain is encapsulated in CrispAct stick packs, offering numerous benefits like reduced risk of bacterial vaginosis, heightened infection resistance, metronidazole resistance, and anti-inflammatory properties. With remarkable adhesion and colonization capabilities, it significantly contributes to vaginal health. Notably, CrispAct showcases biological mechanisms that underlie the development and pathological progression of HPV infection. Additionally, bacterial vaginosis fosters HPV infection persistence and a pro-inflammatory microenvironment that promotes carcinogenesis. Excitingly, after 90 days of using CrispAct, a remarkable 71% of women achieved HPV clearance, highlighting its potential to combat this common infection and its implications.